Pentokey Organy (India)BOM:524210 -1.44%49 Net Margin % is 7.05% as of Mar. 2026, which is 52% below its 10-year median of 14.79. GuruFocus rates BOM:524210 with a GF Score™ of 49/100 and a GF Value™ of ₹26.22 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 1,580 Chemicals companies, Pentokey Organy (India) ranks better than 75.57% on this metric.
The historical rank and industry rank for Pentokey Organy (India)'s Net Margin % or its related term are showing as below:
BOM:524210'
s Net Margin % Range Over the Past 10 Years
Min: -28.35 Med: 14.79 Max: 2071.61
Current: 9.69
BOM:524210's Net Margin % is ranked better than 75.57% of 1580
companies
in the Chemicals industry
Industry Median: 3.905
vs BOM:524210: 9.69
Pentokey Organy (India) (BOM:524210) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Pentokey Organy (India) Net Margin % Related Terms
Pentokey Organy (India) Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Pentokey Organy (India)'s Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pentokey Organy (India) Net Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Pentokey Organy (India)'s Net Margin % distribution charts can be found below:
* The bar in red indicates where Pentokey Organy (India)'s Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pentokey Organy (India) (BOM:524210) has a Net Margin % of 7.05% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Pentokey Organy (India) and its competitors. This is 52% below median its historical median of 14.79. According to the industry distribution chart, Pentokey Organy (India) ranks #386 out of 1580 companies in the Chemicals industry, placing it in the top 24.4%.
Is Pentokey Organy (India)'s Net Margin % too high?
Pentokey Organy (India)'s current Net Margin % of 7.05% is 52% below median its 10-year median of 14.79. The Chemicals industry median Net Margin % is 3.91. Pentokey Organy (India)'s value of 7.05% is 80.5% above this industry median. Based on the distribution chart, Pentokey Organy (India) ranks #386 out of 1580 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Pentokey Organy (India) has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pentokey Organy (India)'s Net Margin % compare to DOW?
According to the Chemicals industry distribution chart, Pentokey Organy (India) ranks #386 out of 1580 companies for Net Margin %. This places Pentokey Organy (India) in the top 24% of its industry — outperforming the majority of peers. The industry median Net Margin % is 3.91. Pentokey Organy (India)'s value of 7.05% is 80.5% above this benchmark. While the company's 10-year median is 14.79 vs. the industry median of 3.91, Pentokey Organy (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Chemicals company?
The median Net Margin % among Chemicals companies is 3.91, based on 1,580 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pentokey Organy (India)'s current Net Margin % of 7.05% is 80.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Pentokey Organy (India) and its competitors. For the Chemicals industry, the median Net Margin % is 3.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pentokey Organy (India)'s current Net Margin % is 7.05%, which is 52% below median its own 10-year median of 14.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pentokey Organy (India) stock overvalued right now?
Based on GuruFocus' analysis, Pentokey Organy (India) (BOM:524210) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹26.22, compared to a current price of ₹38.35 — trading 46.3% above its estimated fair value. The current Net Margin % is 7.05%, which is 52% below median its 10-year median of 14.79 and 80.5% above the Chemicals industry median of 3.91. Pentokey Organy (India)'s overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Pentokey Organy (India) (BOM:524210), the current Net Margin % is 7.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pentokey Organy (India) (BOM:524210) Overvalued in 2026?
Based on GuruFocus' analysis, Pentokey Organy (India) stock appears to be overvalued.
The current stock price of ₹38.35 is trading 46.3% above its estimated GF Value™ of ₹26.22.
GuruFocus considers Pentokey Organy (India) to be Significantly Overvalued.
Key valuation signals for BOM:524210:
Net Margin %: 7.05% (52% below median its 10-year median of 14.79)
GF Value™: ₹26.22 vs. price of ₹38.35 (46.3% above fair value)
Industry Position: 80.5% above the Chemicals median (#386 of 1580)
No single metric tells the full story. See the BOM:524210 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pentokey Organy (India) Ltd is engaged in the trading of Pharmaceutical Goods. It manufactures various chemical products such as Acetic acid, Ethyl acetate, and Acetaldehyde and Butyl acetate. These products are used for various purposes including textile processing, pharmaceuticals, pesticides, printing inks, paints, and coatings, perfumes, polyester resins and basic dyes, solvents and many more. The only segment in which the Company engaged in the Trading of Pharmaceutical Products.
49GF Score
Get the complete analysis for BOM:524210
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524210 has been successfully added to your 
